Evidence map›Paper›PMID 30588231›Full record

ArticleFrontiers in molecular neuroscience2018

Corrigendum: Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.

Nicole M Fisher, Mabel Seto, Craig W Lindsley, Colleen M Niswender

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicole M FisherDepartment of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University , Nashville, TN, United States.
Mabel SetoDepartment of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University , Nashville, TN, United States.
Craig W LindsleyDepartment of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University , Nashville, TN, United States.
Colleen M NiswenderDepartment of Pharmacology and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University , Nashville, TN, United States.
Vanderbilt University · US

Funding

Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRELL, FRANK E. · 2015 to 2019
$7.1M
Development of a Selective Metabotropic Glutamate Receptor 7 Allosteric Modulator ProbeR01MH113543 · NIMH · VANDERBILT UNIVERSITY · PI LINDSLEY, CRAIG, NISWENDER, COLLEEN M · 2017 to 2019
$1.2M
NICHD NIH HHS U54 HD083211NIMH NIH HHS R01 MH113543
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fnmol.2018.00387.].

Indexed as

allosteric modulatorASDGRM7mGlu7Neurodevelopmental disorderRett syndrome

Identifiers

PMID30588231
PMCPMC6302680
OpenAlexW2904154251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.